Anti-Human Lewis Y Reference Antibody (MB 314, RUO) (HP897016)

Name: Anti-Human Lewis Y Reference Antibody (MB 314, RUO)
Brand: abinScience
SKU: HP897016
Price: 326 USD
Availability: InStock

Price(USD): --

Spec:

Number:

Get quote

Overview

Catalog No.	HP897016
Description	Anti-Human Lewis Y Reference Antibody (MB 314, RUO) (HP897016) is a human monoclonal antibody detecting Lewis Y. Expressed in Mammalian cells.
Species reactivity	Human
Applications	ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Host species	Human
Clonality	Monoclonal
Isotype	IgG
Clone ID	MB 314
Expression system	Mammalian cells
Nature	Recombinant
Target	Lewis Y
Endotoxin level	< 10 EU/mg as determined by LAL method.
Purity	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	PubChem CID: 45266908
Form	Liquid
Storage buffer	0.01M PBS pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	MB-314, MB314, MB314
Background	Lewis Y is a protein, also known as SGN-15, SGN15, SGN15, PubChemCID:45266908.
References	1. Kircheis R, et al. Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314. MAbs. 2012 Jul-Aug;4(4):532-41. [HP897016]
Note	For research use only. Not suitable for clinical or therapeutic use.

Images

References

Datasheet

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Overview